Research progress of potential anti-tumor and anti-inflammatory target PARP14
- Author:
Jian ZHOU
1
;
Xian-Hua HUANG
1
;
Xiao-Lu LU
1
;
Jian' LI
1
;
Jin ZHANG
2
Author Information
- Publication Type:Journal Article
- Keywords: anti-cancer; anti-inflammation; antidote; drug targets; inhibitor; PARP14; polyADP-ribosylation
- From: Chinese Pharmacological Bulletin 2022;38(3):347-354
- CountryChina
- Language:Chinese
- Abstract: PARP14 is an intracellular single AI)P-ribose transferase member of the superfamily of polyADP-ribose polymerases.PARP14 is associated with a wide range of biochemical transfor-mations in vivo through poly( ADP-ribosylation, PAKs) modifi- cation of target proteins.For example, it plays an important part in eellular transcriptional regulation, stress response, DNA re-pair, RNA splieing, mitoehondrial function, division, and nu- cleosome formation.PAR PI 4 is elosely related to the development and progression of cancers (such as hepatoeellular carcino- ma, multiple myeloma and pancreatic cancer) , metabolie diseases, and inflammatory diseases, making it a potential dnig dis- eovery target.This research reviews the structure and biological functions of PARP14, and summarizes the role of PARP14 in disease, as well as the existing PARP14 small molecule inhibitors and decompressors.It provides a brief update to the research and development of PARP14 inhibitors and decompressors to assist in the development of selective PARP14 inhibitors and decompressors.It provides reference for the research and development of drugs or chemical sensitizers targeting PARP14.
